Why the study?
Does outpatient management with low-molecular-weight heparin and warfarin safely and cost-effectively treat acute DVT in clinical practice?
Population
391 patients with objectively diagnosed acute deep vein thrombosis (DVT)
Comparison
Outpatient treatment with low-molecular-weight… vs Hypothetical inpatient treatment with…
Design
Cohort
Follow-up
90 days
Authors
Loading...
Supports outpatient DVT management with LMWH in selected patients; hypothesis-generating and leaves open need for randomized confirmation.
Does outpatient management with low-molecular-weight heparin and warfarin safely and cost-effectively treat acute DVT in clinical practice?
Outpatient management of acute DVT with low-molecular-weight heparin is safe, effective, and yields substantial cost savings in real-world clinical practice.
Tillman et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: